Ocular Therapeutix Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 94.6 | 110.8 | 135.0 | 142.0 | 92.6 | 69.4 | 126.5 | 127.7 | 136.5 | 82.6 | 82.5 | 88.1 | 63.9 | 45.9 | 40.9 | 65.6 | 42.5 | 84.0 | 64.6 | 36.1 | 22.2 | 13.3 | 8.4 | 6.6 | 6.5 | 4.5 | 7.9 | 7.4 | 4.6 | 8.4 | 20.1 | 18.5 | 23.6 | 22.4 | 20.7 | 28.3 | 38.6 | 51.9 | 36.6 | 42.4 | |
| 2.8 | 4.0 | 4.0 | 5.6 | 5.0 | 5.1 | 4.6 | 5.6 | 5.9 | 4.6 | 6.9 | 22.9 | 14.0 | – | – | 89.1 | – | 19.2 | 17.2 | 14.5 | 9.8 | 6.6 | 5.2 | 5.0 | 7.0 | 6.6 | 42.2 | 131.5 | 33.6 | 5.4 | 2.9 | 3.0 | 4.1 | 4.5 | 4.7 | 5.2 | 8.3 | 4.1 | 3.3 | 4.2 | |
| 74.4 | 101.6 | 115.6 | 118.2 | 75.5 | 57.2 | 100.9 | 107.1 | 114.8 | 67.9 | 69.6 | 82.5 | 57.3 | 44.9 | 41.4 | 61.2 | 40.8 | 73.8 | 57.4 | 31.8 | 18.9 | 10.7 | 6.5 | 5.0 | 5.2 | 3.6 | 7.5 | 7.3 | 4.0 | 6.3 | 13.1 | 12.1 | 17.8 | 17.4 | 16.1 | 22.7 | 33.7 | 39.2 | 25.2 | 32.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 183.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -21.4% | -17.2% | -16.6% | -17.7% | -31.1% | -44.0% | -24.5% | -20.8% | -17.8% | -31.1% | -33.0% | -34.6% | -46.7% | -41.2% | -30.4% | -15.6% | -13.0% | -3.7% | -3.7% | -5.0% | -6.7% | -11.6% | -16.5% | -18.0% | -18.6% | -27.3% | -16.5% | -19.3% | -29.4% | -16.6% | -7.7% | -8.5% | -8.2% | -9.5% | -12.0% | -11.2% | -9.3% | -8.0% | -12.6% | -11.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 77.5% | 76.5% | 75.9% | 75.9% | 75.8% | 76.2% | 76.4% | 76.4% | 76.6% | 76.6% | 76.1% | 57.5% | 35.2% | 45.0% | 52.5% | 64.2% | 81.8% | 88.0% | 90.3% | 90.3% | 89.7% | 89.9% | 90.2% | 90.2% | 90.7% | 91.2% | 91.4% | 91.6% | 91.5% | 91.0% | 91.0% | 90.8% | 90.6% | 91.2% | 90.7% | 89.4% | 88.9% | 87.3% | 87.2% | 87.1% | |
| -2,269.8% | -2,296.0% | -2,546.7% | -2,931.1% | -3,167.9% | -3,220.1% | -3,339.3% | -2,749.3% | -2,764.9% | -2,970.8% | -3,049.5% | -3,421.5% | -3,300.4% | -2,029.9% | -1,304.5% | -1,088.3% | -567.9% | -361.1% | -300.2% | -213.1% | -192.8% | -179.3% | -153.2% | -150.9% | -155.5% | -152.7% | -161.3% | -153.9% | -141.5% | -141.0% | -152.8% | -187.4% | -229.9% | -269.6% | -342.2% | -402.6% | -449.7% | -519.8% | -575.4% | -603.0% | |
| -2,346.5% | -2,369.0% | -2,620.1% | -3,005.5% | -3,241.2% | -3,296.2% | -3,418.8% | -2,814.7% | -2,822.1% | -3,014.0% | -2,956.9% | -3,450.8% | -3,141.6% | -2,043.3% | -1,430.6% | -1,416.4% | -780.2% | -894.3% | -591.8% | -318.8% | -229.0% | -15.1% | -45.0% | -65.1% | -119.3% | -138.0% | -171.9% | -166.2% | -116.2% | -138.1% | -192.6% | -226.5% | -283.7% | -303.7% | -323.1% | -382.5% | -447.6% | -511.9% | -558.2% | -579.1% | |
| -2,027.4% | -1,903.6% | -2,246.2% | -2,517.2% | -2,879.8% | -3,053.8% | -3,095.5% | -2,653.1% | -2,429.6% | -2,568.6% | -2,725.2% | -3,043.8% | -2,984.8% | -1,888.2% | -1,242.2% | -1,019.6% | -552.1% | -312.6% | -238.6% | -179.9% | -149.0% | -153.4% | -138.0% | -118.8% | -120.6% | -123.0% | -131.2% | -143.8% | -134.6% | -139.5% | -154.2% | -156.8% | -194.1% | -213.4% | -248.8% | -316.5% | -357.5% | -417.5% | -463.0% | -490.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -68.3% | -86.0% | -78.1% | -119.0% | -175.7% | -242.4% | -124.3% | -123.0% | -122.3% | -167.2% | -246.9% | -895.9% | -688.0% | – | – | -1,925.1% | – | -204.5% | -157.1% | -128.2% | -101.1% | -7.4% | -27.8% | -49.4% | -128.4% | -200.8% | -914.6% | -2,939.1% | -853.9% | -88.6% | -28.3% | -36.6% | -49.5% | -61.4% | -72.5% | -70.9% | -96.7% | -40.6% | -50.0% | -58.0% | |
| -51.6% | -59.7% | -55.0% | -71.7% | -98.0% | -114.4% | -79.7% | -79.8% | -79.2% | -82.1% | -62.4% | -82.4% | -87.6% | -109.7% | -124.6% | -95.9% | -97.8% | -59.4% | -53.9% | -44.6% | -40.6% | -3.2% | -11.8% | -18.8% | -37.4% | -47.6% | -69.1% | -74.0% | -41.3% | -32.0% | -21.4% | -26.8% | -35.6% | -42.3% | -47.5% | -48.0% | -60.8% | -32.9% | -39.7% | -44.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -37 | -17 | -37 | -45 | -33 | -24 | -46 | -41 | -43 | -29 | -28 | -12 | -16 | -4.0 | 3.4 | -32 | -20 | -177 | -160 | -140 | -127 | -111 | -92 | -80 | -66 | -47 | -23 | -9.5 | -35 | -119 | -415 | -391 | -358 | -322 | -278 | -319 | -271 | -663 | -591 | -523 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -43.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 75.6% | 69.4% | 70.5% | 60.3% | 55.8% | 47.2% | 64.1% | 64.9% | 64.8% | 49.1% | 25.3% | 9.2% | 12.7% | -4.6% | -14.6% | 5.0% | -4.2% | 29.1% | 34.3% | 34.8% | 40.1% | 43.0% | 42.5% | 38.0% | 29.2% | 23.7% | 7.6% | 2.5% | 4.8% | 36.2% | 75.7% | 73.0% | 71.8% | 68.9% | 65.5% | 67.8% | 62.8% | 81.0% | 79.4% | 77.5% | |
| 0.2 | 0.3 | 0.3 | 0.4 | 0.5 | 0.7 | 0.3 | 0.3 | 0.3 | 0.7 | 1.9 | 6.0 | 4.4 | – | – | 9.9 | – | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 1.2 | 1.6 | 5.8 | 18.5 | 9.6 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.71 | -1.80 | -1.80 | -1.97 | -2.17 | -2.14 | -1.76 | -1.50 | -1.43 | -1.46 | -1.43 | -1.72 | -1.48 | -1.78 | -1.75 | -1.79 | -1.40 | -2.20 | -1.50 | -1.25 | -1.03 | -0.08 | -0.27 | -0.39 | -0.77 | -0.86 | -1.15 | -1.16 | -0.79 | -0.74 | -0.87 | -0.83 | -1.04 | -1.15 | -1.14 | -1.26 | -1.36 | -1.19 | -1.30 | -1.34 | |
| 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.09 | 0.12 | 0.13 | 0.18 | 0.25 | 0.25 | 0.39 | 0.45 | 0.53 | 0.60 | 0.60 | 0.65 | 0.62 | 0.67 | 0.70 | 0.68 | 0.54 | 0.45 | 0.37 | 0.37 | 0.38 | 0.35 | 0.33 | 0.30 | 0.23 | 0.23 | 0.23 | |
| 2.51 | 2.09 | 2.31 | 1.65 | 1.23 | 0.88 | 1.41 | 1.22 | 1.17 | 0.87 | 0.58 | 0.19 | 0.21 | -0.07 | -0.21 | 0.09 | -0.06 | 1.08 | 0.96 | 0.98 | 1.02 | 1.07 | 0.97 | 0.80 | 0.60 | 0.43 | 0.13 | 0.04 | 0.09 | 0.84 | 3.09 | 2.28 | 2.11 | 1.88 | 1.57 | 1.77 | 1.40 | 2.94 | 2.60 | 2.31 | |
| -1.48 | -1.44 | -1.55 | -1.65 | -1.93 | -1.98 | -1.59 | -1.41 | -1.23 | -1.24 | -1.32 | -1.52 | -1.40 | -1.65 | -1.52 | -1.29 | -0.99 | -0.77 | -0.61 | -0.71 | -0.67 | -0.81 | -0.83 | -0.72 | -0.78 | -0.76 | -0.88 | -1.01 | -0.91 | -0.75 | -0.70 | -0.58 | -0.71 | -0.81 | -0.88 | -1.04 | -1.08 | -0.97 | -1.08 | -1.13 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.